Manufactured Object

Schott Pharma Invests Over €100M in New Sterile Cartridge Facility at Hungary Site

3 days ago talkbio0Tagged Automation, Diabetes, expansion, Glucagon-Like Peptide 1, Hungary, Impacts, Environmental, Investments, Lukácsháza, Manufacturing, Pharma, pharma packaging, RTU cartridges, Schott, sterile cartridge facility

Schott Pharma; Hungary; sterile cartridge facility; €100 million investment; RTU cartridges; pharma packaging; manufacturing expansion; Lukácsháza; GLP-1 drugs; diabetes; automation; environmental impact

Recent Developments in NLP and Generative AI for Life Sciences and Precision Medicine (2025)

2 weeks ago talkbio0Tagged Biological Science Disciplines, Drug Discovery, Generative AI, Health care facility, language models, multimodal AI, NINL gene, Pharmacovigilance, Precision Medicine, quality management

NLP; Generative AI; life sciences; precision medicine; healthcare; large language models; multimodal AI; quality management; drug discovery; pharmacovigilance

Sanofi Opens $130M ‘Flagship’ US Office Facility in Morristown, New Jersey

2 weeks ago talkbio0Tagged Corporate, flagship office, Health care facility, innovation, Market, Morristown, sanofi, U.S.

Sanofi; Morristown; flagship office; $130 million; healthcare; innovation; New Jersey; US market; corporate hub

FDA Advisory Committee Unanimously Votes Against Expanding Pfizer’s Prostate Cancer Drug Combo

2 weeks ago talkbio0Tagged Advisory Committees, enzalutamide, expansion, Inhibitor, Labels (device), Malignant neoplasm of prostate, mCRPC, PARP1 gene, Pfizer, talazoparib, Talzenna, unanimous vote, United States Food and Drug Administration

FDA; advisory committee; Pfizer; Talzenna; talazoparib; enzalutamide; prostate cancer; mCRPC; PARP inhibitor; label expansion; unanimous vote

SpyLock Technology: Recent News on Rapid Bispecific Antibody Screening

3 weeks ago talkbio0Tagged BiLockCatcher, Bio-Rad, bispecific antibody screening, Drug Development, high-throughput screening, Laboratory, Pioneer Antibody Discovery, Protein Engineering, SpyLock technology, SpyTag/SpyCatcher

SpyLock technology; bispecific antibody screening; Bio-Rad Laboratories; Pioneer Antibody Discovery Platform; high-throughput screening; protein engineering; SpyTag/SpyCatcher; BiLockCatcher; drug development

Sanofi Commits $20 Billion to U.S. R&D and Manufacturing by 2030

3 weeks ago talkbio0Tagged domestic partnerships, drug launches, Investments, Manufacturing, R&D, sanofi, Surgical construction, United States

Sanofi; $20 billion investment; U.S. manufacturing; R&D; job creation; drug launches; domestic partnerships

Sanofi Announces $20 Billion US Investment Over Five Years

3 weeks ago talkbio0Tagged Big Pharma, development aspects, domestic partnerships, Drug Industry, Investments, Manufacturing, research, sanofi, Surgical construction, tariffs, U.S.

Sanofi; $20 billion investment; US pharmaceutical industry; manufacturing; research and development; tariffs; job creation; Big Pharma; domestic partnerships